Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Silver Spring, United States
Disclosure information not submitted.
Monday, August 26, 2024
5:30 PM – 5:45 PM CEST
Tuesday, August 27, 2024
8:45 AM – 9:00 AM CEST